Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis

[1]  N. Harpaz,et al.  Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  A. Rizzo,et al.  Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. , 2008, Biochemical pharmacology.

[3]  N. Harpaz,et al.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. , 2007, Gastroenterology.

[4]  K R Abrams,et al.  Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease , 2006, Alimentary pharmacology & therapeutics.

[5]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[6]  H. Allgayer.  Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[7]  C. Bernstein,et al.  Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? , 2003, American Journal of Gastroenterology.

[8]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[9]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[10]  P. Prior,et al.  Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. , 1994, Gut.

[11]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[12]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[13]  J. Lennard-jones,et al.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. , 1990, Gut.

[14]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[15]  S. Katz,et al.  Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. , 1983, Gastroenterology.

[16]  J. Macartney,et al.  Cancer morbidity in ulcerative colitis. , 1982, Gut.

[17]  D. Sachar,et al.  A comparison of cancer risk in crohn's disease and ulcerative colitis , 1981, Cancer.

[18]  P. Bejarano.  Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study , 2009 .

[19]  A. Ekbom.  Ulcerative Colitis and Colorectal Cancer , 1991 .

[20]  V. Fazio,et al.  The risk of cancer following colectomy and ileorectal anastomosis for extensive mucosal ulcerative colitis. , 1981, Annals of surgery.